BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:32 PM
 | 
Jun 19, 2007
 |  BC Extra  |  Company News

Ixabepilone gets Priority Review

FDA accepted for filing and granted Priority Review to an NDA from Bristol-Myers...

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >